Clinical Trials Logo

Coronary Artery Bypass, Off-Pump clinical trials

View clinical trials related to Coronary Artery Bypass, Off-Pump.

Filter by:
  • None
  • Page 1

NCT ID: NCT06399627 Recruiting - Iron Deficiencies Clinical Trials

Effect of Non-anemic Iron Deficiency on Outcome Following Off-pump Coronary Revascularization

Start date: November 1, 2016
Phase:
Study type: Observational

This is a single center retrospective study of patients who underwent off pump coronary artery bypass surgery between 2016.11~2023.05. From this patient group, preoperatively non-anemic patients were selected and were divided into 2 cohorts according to their preoperative iron status; iron replete and iron deficient. These two cohorts were compared to evaluate the effect of preoperative iron deficiency on patient outcomes. The primary end point was the occurrence of composite morbidity/mortality end points which were: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction. Occurrence of any one of these outcomes counted as primary end point met. Secondary outcome was to evaluate and compare hemoglobin recovery of iron replete and deficient patients until one year after surgery.

NCT ID: NCT04795193 Not yet recruiting - Clinical trials for Coronary Artery Bypass, Off-Pump

Efficacy and Safety of Minimal Invasive Coronary Surgery in Patients With Complex Coronary Artery Lesions

Start date: April 2021
Phase: N/A
Study type: Interventional

The aim of this study is to investigate and compare the mid-term safety and efficacy end-points [medical outcomes study-short form 36-item (SF-36) physical component summary (PCS) at 30 days after surgery, etc.] in patients with complex coronary artery lesions [an indication of off-pump coronary artery bypass surgery (OPCAGB)] who received minimal invasive coronary surgery (MICS)-CABG and those who received thoracotomy OPCABG. The investigators hypothesize that patients in MICS-CABG group have superior clinical demonstrations regarding the primary endpoint than those in OPCAGB group without increased adverse outcomes. A total of 200 eligible patients are planned to be randomized to MICS-CABG or OPCABG group with an allocation ratio of 1:1. The primary endpoint is SF-36 PCS at 30 days after surgery. The analysis on primary endpoints will be conducted according to the basic principle of intention-to-treat (ITT).

NCT ID: NCT04267835 Recruiting - Clinical trials for Coronary Artery Bypass, Off-Pump

Prospective Cohort Study on Minimal Invasive Coronary Surgery

PCSMICS
Start date: April 4, 2020
Phase:
Study type: Observational

CABG technology is recognized as the preferred treatment, and its major adverse cardiac and cerebral event(MACCE) incidence and mortality are lower than percutaneous coronary intervention(PCI). However, the traditional CABG procedure requires sternal incision, large trauma and long recovery period after surgery. How to reduce trauma and treat multiple complex coronary lesions under minimally invasive conditions has become a hot spot. MIDCAB surgery can complete the coronary anastomosis only by a 6-8 cm incision in the left chest. It has been more than ten years since the first literature report in the world, however, due to the technical bottleneck, a unified and standardized surgical procedure has not yet been formed. Some centers are still in the exploratory stage, and internationally Large-scale studies of clinical outcomes (mostly less than 150 cases) have not been reported. Assessing the minimally invasive procedure's safety and effectiveness has become an urgent problem to be solved. At present, our center has completed nearly 200 cases of small incision multi-coronary coronary artery bypass graft surgery. The investigators evaluate the patency of the graft by the postoperative of angiography, the patency of grafts is more than 95%, and there is no statistical difference with conventional OPCABG. On the other hand, focus on the postoperative complications, there was no significant difference in the incidence of MACCE and revascularization between the MIDCAB group and conventional surgery during hospitalization. The investigators assume that the early results of this procedure are safe and effective. MIDCAB has a congenital advantage because of its' reduction of the trauma of the thoracotomy and the aesthetics of the incision. Therefore, if a larger sample size study and mid-term follow-up results are obtained, and the conclusion prove that the safety of the small incision surgery and the patency of the grafts are not inferior to conventional surgery. The investigators can consider that minimal invasive coronary surgery(MICS) is a technique worth trying to promote. Through this prospective cohort study, the investigators evaluated the safety of MICS through mid-term follow-up results and asses the efficiency by the results of grafts patency (angiography or CT within 30 days after surgery) and medical outcomes study-short from scores(SF-36), establish the surgical standard and perioperative management method.

NCT ID: NCT03889730 Completed - Acute Kidney Injury Clinical Trials

Intraoperative Hypotension and Acute Kidney Injury After Off-pump Coronary Artery Bypass Grafting Surgery

Start date: March 3, 2019
Phase:
Study type: Observational

Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. Hypotension is an important risk factor for the development of AKI after noncardiac surgery. However, the association between intraoperative hypotension and AKI after cardiac surgery has not been fully investigated. The purpose of this study is to analyze the association between intraoperative hypotension and acute kidney injury after off-pump coronary artery bypass surgery.

NCT ID: NCT03629418 Recruiting - Acute Kidney Injury Clinical Trials

Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery

Start date: August 14, 2018
Phase: N/A
Study type: Interventional

Acute renal injury (AKI) is a common complication after cardiac surgery and is associated with worse outcomes. It is now realized that intraoperative hypotension is an important risk factor for the development of AKI. In a recent randomized controlled trial of patients undergoing major noncardiac surgery, intraoperative individualized blood-pressure management reduced the incidence of postoperative organ dysfunction. The investigators hypothesize that, for patients undergoing off-pump CABG, targeted blood-pressure management during surgery may also reduce the incidence of postoperative AKI.

NCT ID: NCT03163693 Active, not recruiting - Clinical trials for Coronary Artery Bypass, Off-Pump

The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG

Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients undergoing off-pump coronary artery bypass Grafting.

NCT ID: NCT02046824 Terminated - Clinical trials for Coronary Artery Bypass, Off-Pump

Cell Savers and Blood Quality

Start date: January 2014
Phase: N/A
Study type: Interventional

Cell savers are routinely used in our hospital during off-pump coronary artery bypass grafting to retrieve and wash blood that is lost during the operation. This washed blood is retransfused to the patient in order to prevent allogeneic blood transfusion. However, little is known about the rheologic properties and oxygen transport capacity of the washed red blood cells and the effects of retransfusion of this blood on microcirculatory blood flow and organ damage in the patient. For cell savers 3 different operating principles exist. The most common one uses discontinuous blood washing with a spinning bowl that is intermittently filled with blood, processed and emptied. A second one uses a continuous blood washing principle with a rotational disk. A third one is intermediate using features of both the discontinuous bowl technology and the continuous rotational disc technology. The investigator hypothesize that the operating principle has effects on the rheologic properties and oxygen transport capacity of the washed blood. Previous research suggested that in particular the deformability and oxygen carrier properties of the red blood cells are affected. As a consequence, red blood cells may block small blood vessels, which affects microcirculatory blood flow and tissue oxygenation. This may lead to organ damage.